Paolo Parma

542 citations
13 papers · 171 indexed · h-index 7
Topics
Renal cell carcinoma treatment (5 papers)Bladder and Urothelial Cancer Treatments (4 papers)Urological Disorders and Treatments (4 papers)
Partner nations
ItalyChileGreece

In The Last Decade

Paolo Parma

12 papers receiving 170 citations

Peers

Paolo Parma
Comparison fields: 5 of 35
  • Surgery 103
  • Pulmonary and Respiratory Medicine 84
  • Molecular Biology 37
  • Endocrinology, Diabetes and Metabolism 29
  • Cancer Research 25
Replace J Bolt with:
J Bolt Australia
Paulo Emílio Fuganti Brazil
N. Antoniou Greece
James Chrystal United States
Walsh Pc United States
Aušvydas Patašius Lithuania
E. David Crawford United States
Isabelle Rieger France
Zechao Lu China
George Bartsch Austria
Paolo Parma relative to J Bolt Australia J Bolt's profile →
Citations per field
00.5×10×15×
J Bolt · 1×
Citations per year

Countries citing papers authored by Paolo Parma

Since Specialization
Citations

This map shows the geographic impact of Paolo Parma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Parma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Parma more than expected).

Fields of papers citing papers by Paolo Parma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Parma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Parma. The network helps show where Paolo Parma may publish in the future.

Co-authorship network of co-authors of Paolo Parma

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Parma. A scholar is included among the top collaborators of Paolo Parma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Parma. Paolo Parma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 11
2 6
3 24
4 6
5 6
6 19
7 2
8 13
9 3
10 52
11 23
12
Pubo-vaginal sling.
0
13
[Complications of urinary diversion after radiotherapy].
6

About Paolo Parma

Paolo Parma is a scholar working on Urology, Obstetrics and Gynecology and Pulmonary and Respiratory Medicine, having authored 13 papers that have together received 171 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (5 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Urological Disorders and Treatments (4 papers). The work is most often cited by research in Urology (23 citations), Pulmonary and Respiratory Medicine (84 citations) and Surgery (103 citations). Paolo Parma has collaborated with scholars based in Italy, Chile and Greece. Frequent co-authors include Octavio Castillo, Gonzálo Vitagliano, M. A. Cruz Díaz, Emma Gallo, Fabio Ragaini, Piero Macchi, Michela Gasperini, Nicola Casati, Antonio Celia and Alessandro Antonelli. Their work appears in journals such as The Journal of Urology, Urology and New Journal of Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026